| Autor: |
Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Greece ekastritis@gmail.com., Kyrtsonis MC; Hematology Section of the First Department of Propedeutic Internal Medicine, Laikon University Hospital, National and Kapodistrian University of Athens, School of Medicine, Greece., Morel P; Service D'Hématologie Clinique et Thérapie Cellulaire CHU (University Hospital), Amiens, France., Gavriatopoulou M; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Greece., Hatjiharissi E; Theagenion Cancer Center, Department of Hematology, Thessaloniki, Greece., Symeonidis AS; University of Patras, Hematology Division, Patras, Greece., Vassou A; University of Ioannina, Hematology Division, Ioannina, Greece., Repousis P; Peripheral General Anticancer Hospital-Metaxa, Department of Hematology, Piraeus, Greece., Delimpasi S; Evangelismos Hospital, Hematology Department, Athens, Attica, Greece., Sioni A; St Savvas Oncology Hospital, Hematology Division, Athens, Greece., Michalis E; G.Gennimatas General Hospital, Department of Hematology, Athens, Greece., Michael M; Department of Haematology, Nicosia General Hospital, Cyprus, Greece., Vervessou E; Henry Dunant Hospital, Hematology Division, Athens, Greece., Voulgarelis M; Department of Pathophysiology, National And Kapodistrian University of Athens, School of Medicine, Greece., Tsatalas C; Democritus University of Thrace, Alexandroupolis, Greece., Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Greece., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Greece. |
